Business Description
![Oragenics Inc Oragenics Inc logo](https://static.gurufocus.com/logos/0C00000C0V.png?14)
Oragenics Inc
NAICS : 325412
SIC : 2834
ISIN : US6840233026
Description
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 16.32 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31.1 | |||||
3-Year EPS without NRI Growth Rate | 31.3 | |||||
3-Year FCF Growth Rate | 41.1 | |||||
3-Year Book Growth Rate | -56.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.5 | |||||
9-Day RSI | 35.03 | |||||
14-Day RSI | 36.35 | |||||
6-1 Month Momentum % | -78.96 | |||||
12-1 Month Momentum % | -74.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.69 | |||||
Quick Ratio | 2.69 | |||||
Cash Ratio | 2.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.3 | |||||
Shareholder Yield % | -28 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -340.07 | |||||
ROA % | -273.87 | |||||
ROIC % | -1561.28 | |||||
ROC (Joel Greenblatt) % | -1710.18 | |||||
ROCE % | -337.57 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.59 | |||||
Price-to-Tangible-Book | 4.59 | |||||
EV-to-EBIT | -0.26 | |||||
EV-to-EBITDA | -0.26 | |||||
EV-to-FCF | -0.64 | |||||
Price-to-Net-Cash | 4.06 | |||||
Earnings Yield (Greenblatt) % | -384.62 | |||||
FCF Yield % | -140.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:OGEN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oragenics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -8.54 | ||
Beta | 1.28 | ||
Volatility % | 153.47 | ||
14-Day RSI | 36.35 | ||
14-Day ATR ($) | 0.09673 | ||
20-Day SMA ($) | 1.06755 | ||
12-1 Month Momentum % | -74.74 | ||
52-Week Range ($) | 0.97 - 7.74 | ||
Shares Outstanding (Mil) | 5.58 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Oragenics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Oragenics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Oragenics Inc Frequently Asked Questions
What is Oragenics Inc(OGEN)'s stock price today?
The current price of OGEN is $1.06. The 52 week high of OGEN is $7.74 and 52 week low is $0.97.
When is next earnings date of Oragenics Inc(OGEN)?
The next earnings date of Oragenics Inc(OGEN) is 2024-08-09 Est..
Does Oragenics Inc(OGEN) pay dividends? If so, how much?
Oragenics Inc(OGEN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |